Chain Drug Review

3 days ago | chaindrugreview.com | Bill Schiffner

DEERFIELD, Ill. — Walgreens is calling on the public to help in the fight against prescription drug abuse by participating in National Prescription Drug Take Back Day on Saturday, April 26, 2025. Drug take-back days are reserved annually for the safe disposal of unwanted, unused, or expired medications. Walgreens has more than 1,500 kiosks across 46 states and Washington, D.C. These kiosks are a convenient way to ensure medications are not accidentally or intentionally misused.

3 days ago | chaindrugreview.com | Bill Schiffner

VAUGHAN, Ontario — Bausch + Lomb Corp. announced Monday its exclusive ONE by ONE Recycling and Biotrue Eye Care Recycling programs have collected a total of 103,169,500 units, or 625,026 pounds, of used contact lenses, eye care and lens care materials in the United States. That’s equivalent to the weight of approximately 600 concert grand pianos.

6 days ago | chaindrugreview.com | Bill Schiffner

DOWAGIAC, Mich. – Cass Family Clinic, an independent Federally Qualified Health Center (FQHC) serving Southwest Michigan, has kicked off construction of its new Dowagiac health care clinic in the former Community Care of Dowagiac building on M-51. The new clinic will be Cass Family Clinic’s third location when it opens late summer 2025, joining the organization’s Cassopolis and Niles locations.

6 days ago | chaindrugreview.com | Bill Schiffner

Pharmacy — Retail News — CVS Health "HB1150 is bad policy that accomplishes just the opposite. It will take away access to pharmacy care in local communities, hike prescription drug spending across the state by millions of dollars each year and cost hundreds of Arkansans their jobs.” WOONSOCKET, R.I. — CVS Health has issued a statement in response to House Bill 1150, which prevents pharmacy benefits managers from owning pharmacies in Arkansas.

1 week ago | chaindrugreview.com | Bill Schiffner

INDIANAPOLIS— Eli Lilly and Co. announced success Thursday of its Phase 3 clinical trial for a once-daily GLP-1 pill — an oral form of the blockbuster medication used for diabetes and weight loss. The trial of the drug, orforglipron, measured its efficacy and safety in adults with Type 2 diabetes compared to a placebo. It found the pill lowered A1C, a blood level used to diagnose diabetes, by an average of 1.3% to 1.6%, across different doses, after 40 weeks.